• Company Type For Profit
  • Contact Email info@argutusmed.com
  • Phone Number +353-1-670-8576

Argutus Medical is a world leader in developing and manufacturing specialised organ injury assays.

Argutus Medical primarily focuses on developing ELISA tests and lateral flow rapid test devices for detection of acute kidney injury (Nephrotoxicity) and acute liver injury (Hepatotoxicity). Argutus also manufactures a range of other assays

including OxyDNA, a unique test for oxidative DNA damage (Genotoxicity).

Argutus Medical was previously part of Biotrin International before branching out in 2008. In 2010 Argutus Medical was acquired by EKF Diagnostics Holdings plc, a rapidly growing global health care company. Being part of EKF Diagnostics has allowed Argutus Medical to continue to focus on biomarker discovery and development of novel biomarker assays from their facility in Dublin, Ireland.

Lists Featuring This Company

Dublin Companies that Exited
775 Number of Organizations • $46.1B Total Funding Amount • 636 Number of Investors
Health Diagnostics Companies With More Than 10 Employees (Top 10K)
9,865 Number of Organizations • $149.5B Total Funding Amount • 8,405 Number of Investors
Ireland Companies With Fewer Than 100 Employees
7,727 Number of Organizations • $20B Total Funding Amount • 3,052 Number of Investors
Dublin Companies With Fewer Than 50 Employees
4,631 Number of Organizations • $8.3B Total Funding Amount • 1,881 Number of Investors
Argutus Medical was acquired by EKF Diagnostics for £2.2M on Dec 8, 2010.

Frequently Asked Questions

Where is Argutus Medical's headquarters? Argutus Medical is located in Dublin, Dublin, Ireland.